Skip to main content
. Author manuscript; available in PMC: 2011 Aug 16.
Published in final edited form as: Prog Pediatr Cardiol. 2009 Dec 1;27(1-2):13–23. doi: 10.1016/j.ppedcard.2009.09.004

Fig. 4.

Fig. 4

Kaplan–Meier curves for survival and treatment success in all patients with IPAH who received epoprostenol (n=37). Survival rates at 1, 3, 5, and 10 years were 94, 88%, 81%, and 61% respectively; treatment success rates at 1, 3, 5, and 10 years were 83%, 65%, 57%, and 37%, respectively.

Yung D, et al. Circulation 2004; 110:497–503.